< Back to previous page
Researcher
Paul Clement
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Department of Oncology (Department)
Responsible
From1 Aug 2024 → Today - Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2006 → Today
Projects
1 - 10 of 11
- Aggressive salivary gland neoplasms: institutional-international collaborative evaluation of advances in clinical management and translational research into tumor biologyFrom22 Jan 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A prospective national study for early cancer detection in germline TP53 mutation carriersFrom16 Dec 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- GlioSELECT: A multi-omic single-cell, functional precision oncology platform to guide personalized medicine in high-grade brain tumorsFrom1 Oct 2024 → TodayFunding: FWO Strategic Basic Research (SBO)
- The malignant Glioma immuno-oncology matchmaker: towardsdata-driven precision medicine using spatially resolved radio-multiomicsFrom1 Apr 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Evaluating the clinical utility of minimally-invasive cfDNA analysis for surveillance and early cancer detection in germline TP53 mutation carriersFrom1 Oct 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Aggressive salivary gland neoplasms: institutional-international collaborative evaluation of advances in clinical management and translational research into tumor biologyFrom11 Jan 2022 → 31 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Proof of concept: immunotherapy in glioblastoma multiforme.From21 Sep 2020 → TodayFunding: FWO fellowships
- Single-Cell Omics to Reveal Mechanisms of Response to Immunotherapy in Head and Neck CancerFrom1 Sep 2019 → 15 Apr 2024Funding: Foundations, funds and other with scientific goal
- Novel applications for immune checkpoint blockers in head and neck cancerFrom1 Sep 2018 → 19 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Determination of genetic and therapeutic dependencies of patient-derived models of brain cancerFrom1 Oct 2017 → 30 Sep 2021Funding: Fund Recuperation Fiscal Exemption
Publications
1 - 10 of 155
- Impact of time-of-day administration of immune checkpoint inhibitors on survival outcomes in patients with recurrent/metastatic head and neck cancer (R/M HNSCC): a retrospective cohort study(2025)Published in: Oral OncologyISSN: 1368-8375Volume: 171
- A multi-code, multi-physics approach investigating the impact of vegetation on prompt gamma-ray energy deposition(2025)Published in: Journal of Defense Modeling and Simulation-Applications Methodology Technology-JDMSISSN: 1548-5129
- Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment(2025)Published in: CELL REPORTS MEDICINEISSN: 2666-3791Issue: 10Volume: 6
- Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling(2025)Published in: Nature CancerIssue: 10Volume: 6
- The concept, intention, and evaluation of the term treatment-refractory meningioma(2025)Published in: Journal of Neuro-OncologyISSN: 0167-594X
- Primary vs. second primary cT1- T2 oral squamous cell carcinoma: comparing the outcomes(2025)Published in: Frontiers in surgeryISSN: 2296-875XVolume: 12
- Regionalism and Revolution: CARICOM and the Grenada Revolution(2025)Published in: Latin American PerspectivesISSN: 0094-582XIssue: 4Volume: 52Pages: 73 - 88
- INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma(2025)Published in: CLINICAL CANCER RESEARCHISSN: 1078-0432Issue: 13Volume: 31Pages: 2617 - 2627
- Structural Network Hubs as Potential Organs at Risk in Glioma Patients After Radiation Therapy(2025)Published in: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSISSN: 0360-3016Issue: 3Volume: 122Pages: 631 - 642
- Increased functional network segregation in glioma patients posttherapy: A neurological compensatory response or catastrophe for cognition?(2025)Published in: Netw NeurosciISSN: 2472-1751Issue: 2Volume: 9Pages: 743 - 760